Lung cancer patients with high MET amplification appear to do well on Xalkori (crizotinib), a drug that is approved for ALK positive patients....
Lung cancer patients with high MET amplification appear to do well on Xalkori (crizotinib), a drug that is approved for ALK positive patients....
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side...
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side...
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial. [powerpress]
Hi Doc, My dad had stage1 Adenocarcinoma.My dad's labectomy was done in Jan 2015. In Dec 2016 it metastasize to his right hip area. he got radiation....
Dr. Jack West founded GRACE to help provide quality cancer education to patients and caregivers, but that's not his only cancer education project. In...
Hi, My father-in-law just got admitted to ICU from ER due to heavy urine bleeding (the ER doctor couldn't stop the bleeding). He is 97yo and diagnosed...
My wife's biopsy shows 70% PD-L1 so they are going to start her on Keytruda this week, my concern is she has been feeling terrible, fever, shortness...
Im interested in knowing, whats the allowed growth of AST and ALT to stop using xalkori?
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.